Venmax Drugs & Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

5.24

5.24

5.24

5.24

5.24

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

-5.95

-6.18

-8.03

-7.86

-7.59

Loan funds

Secured loans

0.35

0.35

2.33

2.52

2.24

Unsecured loans

-

-

-

-

-

Total

-0.36

-0.59

-0.46

-0.10

-0.11

Uses of funds

Fixed assets

Gross block

0.09

0.11

0.11

0.11

0.11

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

0.01

0.03

0.02

0.01

-

Net block

0.07

0.08

0.09

0.10

0.11

Capital work-in-progress

-

-

-

-

-

Investments

-

-

-

-

-

Net current assets

Current assets, loans & advances

0.14

0.13

0.22

0.35

0.22

Less : current liabilities & provisions

0.57

0.80

0.76

0.56

0.44

Total net current assets

-0.44

-0.67

-0.55

-0.21

-0.22

Miscellaneous expenses not written

-

-

-

-

-

Total

-0.36

-0.59

-0.46

-0.10

-0.11

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

52.39

52.39

52.39

52.39

52.39